Editas Medicine, Inc. (EDIT) has 12 SEC Form 4 insider filings on record in the last 90 days. No insider purchases were filed — 5 sales totalling $34K. Most recent filing: Sept. 9, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| Sept. 9, 2026 filed Sept. 8, 2026 | Ory Daniel Scott EVP, Chief Medical Officer | $0 | 950,000 | 0% | No | |
|
|
||||||
| Sept. 4, 2026 filed Sept. 3, 2026 | Burkly Linda EVP, CHIEF SCIENTIFIC OFFICER | −$2,153 | 709 | −1% | Yes | |
|
|
||||||
| Sept. 4, 2026 filed Sept. 3, 2026 | Parison Amy SVP, Chief Financial Officer | −$1,376 | 453 | −3% | Yes | |
|
|
||||||
| Sept. 4, 2026 filed Sept. 3, 2026 | O'Neill Gilmore Neil CEO | −$15,563 | 5,124 | −2% | Yes | |
|
|
||||||
| Aug. 7, 2026 filed Aug. 6, 2026 | Ellinor Patrick Thomas II Director | $0 | 103,400 | 0% | No | |
|
|
||||||
Showing the 5 most recent of 12 filings in the last 90 days.
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free